high-dose cytarabine

DRUG2 trials

Sponsors

Cephalon, St. Jude Children's Research Hospital

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaLeukemia, B-CellLeukemia, T-CellLymphoma, Non-Hodgkin's

Phase 2

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

CompletedNCT00079482

CephalonAcute Myeloid Leukemia

Start: 2003-10-31End: 2010-01-31Updated: 2016-07-21

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

TerminatedNCT02518750

St. Jude Children's Research HospitalAcute Lymphoblastic Leukemia, Leukemia, B-Cell, Leukemia, T-Cell +1

Start: 2016-11-23End: 2018-03-11Updated: 2019-04-03

Related Papers

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.

2011-01-26311 citations